Streetbeat News

Earnings

FRFHF

Fairfax Finl Hldgs (OTC:FRFHF) is set to release its latest quarterly earnings report on August 3, 2023. Analysts estimate an earnings per share (EPS) of $50.09. The company's past performance shows a mix of EPS beats and misses, with the stock price fluctuating accordingly. Fairfax's shares were trading at $800.0 as of August 1, with a 52.09% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:24 am

CHUY

Chuy's Holdings (NASDAQ:CHUY) is set to release its latest quarterly earnings report on August 3, 2023. Analysts estimate an earnings per share (EPS) of $0.53. The company's past performance shows a trend of beating EPS estimates, which has often resulted in a share price increase. The company's shares were trading at $41.19 as of August 1, with a 74.31% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:23 am

LNG

Cheniere Energy (AMEX:LNG) is set to release its quarterly earnings report on August 3, 2023. Analysts estimate an EPS of $2.37. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price the following day. The stock is currently trading at $160.25, up 10.21% over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:23 am

TEVA

Teva Pharmaceutical Industries Ltd's Q2 sales reached $3.88 billion, up 2% Y/Y, slightly beating the consensus of $3.70 billion. Austedo sales are up 51% in North America to $308 million. The company revised its FY23 revenue forecast to $15.0-$15.4 billion from $14.8-$15.4 billion. TEVA shares are up 10% at $9.12.

Portfolio Pulse from Vandana Singh

August 04, 2023 | 11:23 am

WW

WW International has an option alert for January 19 $5 calls at the ask price of $6.29, compared to an open interest of 7911. The company is expected to announce earnings on August 3 after market close. The reference price is $10.68.

Portfolio Pulse from Charles Gross

August 04, 2023 | 11:23 am

DKNG

DraftKings (NASDAQ:DKNG) is set to release its quarterly earnings report on August 3, 2023. Analysts estimate an earnings per share (EPS) of $-0.25. The company's past performance shows a trend of beating EPS estimates, which has often led to an increase in share price. The stock is currently trading at $31.55, up 87.47% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:23 am

PBR

Petrobras Brasileiro (NYSE:PBR) is set to release its quarterly earnings report on August 3, 2023. Analysts estimate an earnings per share (EPS) of $0.97. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $14.19, down 1.34% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:23 am

BWA

BorgWarner Inc (NYSE:BWA) reported Q2 FY23 sales growth of 20% Y/Y to $4.52 billion, exceeding the consensus of $4.39 billion. The company's revenue benefited from higher demand for products and recoveries from its customers of material cost inflation. BorgWarner also revised its FY23 sales outlook to $14.2 billion-$14.6 billion. Despite the positive earnings report, BWA shares are trading lower by 2.40% at $45.35.

Portfolio Pulse from Lekha Gupta

August 04, 2023 | 11:22 am

TEVA

Teva Pharmaceutical Industries Ltd's Q2 sales reached $3.88 billion, up 2% Y/Y, slightly beating the consensus of $3.70 billion. The company's adjusted EPS of $0.56 came ahead of the Wall Street estimate of $0.54. Teva revised its FY23 revenue forecast to $15.0-$15.4 billion from $14.8-$15.4 billion. The company's shares are up 10% at $9.12 on the last check Wednesday.

Portfolio Pulse from Vandana Singh

August 04, 2023 | 11:22 am

ADMP

CMBM

IDAI

LTCH

MEDS

PSX

WAVD

The Dow Jones fell over 100 points, with NASDAQ and S&P 500 also experiencing drops. Phillips 66 reported better-than-expected Q2 results, with an EPS of $3.87 and revenue of $35.74 billion. WaveDancer, T Stamp, and TRxADE HEALTH saw significant stock increases, while Adamis Pharmaceuticals, Cambium Networks, and Latch experienced drops. Adamis announced the pricing of an $8 million public offering, Cambium reported worse-than-expected Q2 results, and Latch does not anticipate regaining compliance with its periodic filing obligations before its deadline.

Portfolio Pulse from Lisa Levin

August 04, 2023 | 11:22 am